DENTSPLY International Announces Receipt of Regulatory Approvals and Anticipated Closing Date for Acquisition of Astra Tech from AstraZeneca
DENTSPLY International Inc. (Nasdaq: XRAY) today announced that it has received regulatory approval from the relevant national competition authorities to proceed with the acquisition of the shares of Astra Tech AB, a leading provider of dental implant and urology products, based in Mölndal, Sweden, from AstraZeneca. The previously announced transaction is now expected to close on August 31, 2011.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.